MobiHealth News September 9, 2025
The company will use the funds to improve its value-based care model, including its AI and analytics tools, and expand its partnerships and services.
Denver-based kidney care company Strive Health has secured $300 million in Series D equity and $250 million in debt financing, totaling $550 million in its Series D capital raise.
New Enterprise Associates led the equity funding, with participation from CVS Health Ventures, Echo Health Ventures, Redpoint, Town Hall Ventures and CapitalG (Alphabet).
Several new investors, including funds and accounts, also participated in the raise.
WHAT IT DOES
Strive Health offers a value-based care platform that integrates chronic kidney disease and end-stage renal disease patient data from various systems into one platform.
The technology...
Today's Sponsors
Today's Sponsor